chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 31.0
Sex: M
Vaccine: TDAP
Symptoms: Globulins increased, HIV test negative, Hepatitis viral test negative, Hypoaesthesia, Intervertebral disc protrusion
Clinical narrative: Patient with increased numbness and with progressive numbness in hands. Progressive ataxia and unable to walk without assistance. Patient also reporting an URI.
Age: 31.0
Sex: M
Vaccine: TDAP
Symptoms: Nuclear magnetic resonance imaging brain normal, Nuclear magnetic resonance imaging spinal abnormal, Protein total increased, Red blood cells CSF positive, Treponema test negative
Clinical narrative: Patient with increased numbness and with progressive numbness in hands. Progressive ataxia and unable to walk without assistance. Patient also reporting an URI.
Age: 31.0
Sex: M
Vaccine: TDAP
Symptoms: Upper respiratory tract infection, Walking aid user
Clinical narrative: Patient with increased numbness and with progressive numbness in hands. Progressive ataxia and unable to walk without assistance. Patient also reporting an URI.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Immediate post-injection reaction, Injection site pain, Pain, Pain in extremity
Clinical narrative: Received Flu vax at doctor's office by nurse. The shingles vax stung going in. By the afternoon arm started to throb and had to take medicine. Lesion, red, itching bad and raised. Lesion got worse overnight it feels solid, red about 6 3/4 by 4 1/2. Today it is itchy but too sore to scratch.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus, Skin lesion, Swelling, Tenderness
Clinical narrative: Received Flu vax at doctor's office by nurse. The shingles vax stung going in. By the afternoon arm started to throb and had to take medicine. Lesion, red, itching bad and raised. Lesion got worse overnight it feels solid, red about 6 3/4 by 4 1/2. Today it is itchy but too sore to scratch.
Age: 43.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: I read that the ZOSTAVAX can cause issues, I am reporting mine which seems to be possible side effects. At injection site after 24 hours some redness, warmth and swelling. After 48 hours swelling, redness approximately 4 inches by 2 inches, tenderness, very warm to the touch. I have applied ice a couple times and taken an anti-inflammatory  but I cannot tolerate BENADRYL. It has been about 51 hours and continuing to worsen. No tongue swelling or difficulty breathing or hives.
Age: 39.0
Sex: M
Vaccine: ANTH
Symptoms: Amnesia, Arthralgia, Dizziness, Fatigue, Hypoaesthesia
Clinical narrative: Migraines, chronic fatigue, dizziness, muscle and joint pain, night sweats, short term memory loss unexplained skin rashes or infections, vision problems, seeing spots, and extreme tingling or numbing in all limbs.
Age: 39.0
Sex: M
Vaccine: ANTH
Symptoms: Migraine, Myalgia, Night sweats, Paraesthesia, Rash
Clinical narrative: Migraines, chronic fatigue, dizziness, muscle and joint pain, night sweats, short term memory loss unexplained skin rashes or infections, vision problems, seeing spots, and extreme tingling or numbing in all limbs.
Age: 39.0
Sex: M
Vaccine: ANTH
Symptoms: Skin infection, Visual impairment
Clinical narrative: Migraines, chronic fatigue, dizziness, muscle and joint pain, night sweats, short term memory loss unexplained skin rashes or infections, vision problems, seeing spots, and extreme tingling or numbing in all limbs.
Age: 55.0
Sex: F
Vaccine: FLU4
Symptoms: Myalgia
Clinical narrative: Muscle soreness with movement and pressure, no redness, swelling, or infection present.
Age: 29.0
Sex: F
Vaccine: FLUX
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: Had flu vaccine. Experienced pain around injection site in upper left shoulder. I was warned that there would be residual soreness so I was not alarmed about the pain until it never went away and felt deep in the shoulder. Pain has continued in upper left shoulder for several months and I have limited range of motion. Particularly difficult to move arm across chest or lift it above 90 degrees. Have had 3+ doctors' appointments to try to resolve the problem. Currently taking Norco, ibuprofen and starting physical therapy. Doctors believe it could be subacromial bursitis or adhesive capsulitis. Have not had any MRI or x-rays.
Age: 40.0
Sex: F
Vaccine: FLUX
Symptoms: Bursitis, Rotator cuff syndrome
Clinical narrative: Shoulder bursitis with some concern for rotator cuff injury. Attempting conservative therapy with ice and NSAIDs before further imaging/intervention attempted. Immunization given too proximal to joint per pt hx of immunization.
Age: 66.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site pain, Myalgia, Pain in extremity
Clinical narrative: Upon receiving vaccination, patient already felt her arm was sore.  She tried rubbing the site to soothe it and self treated with Tylenol 500mg 2 tabs 2-3 times per day (that day and almost every day thereafter).  The patient was vaccinated almost three weeks ago but still feels muscle pain and soreness/achiness.  Achiness is only around injection site.  No sharp, shooting pain or tingling.  No burning sensations.
Age: 0.39
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Abdominal rigidity, Crying, Discomfort, Intussusception, Ultrasound abdomen abnormal
Clinical narrative: About 10 PM the child began to cry uncontrollably, appeared very uncomfortable, and his abdomen was hard to the touch.  Ultrasound consistent with intussusception.
Age: 21.0
Sex: M
Vaccine: ANTH
Symptoms: Adrenal medulla hyperfunction, Anxiety, Blindness, Chest pain, Disturbance in attention
Clinical narrative: Aug 2013: Experienced Complete Blindness w/ Exertion. Chest pain/Tachycardia/Dyspnea/High Blood Pressure/Headaches/Extreme heart Burn/Difficulty concentrating/focusing. March 2014: Symptoms worsened to include extreme fatigue, dyspnea progressed to having to rest after minor exertion. IBS potentiality. Vit D deficiency. Found melloadrenal hyperfunction. MIBG scan shows holding of adrenaline in kidneys. Anxiety. Put on Metoprolol 100mg for Heart Rate/BP. Zantac and Prilosec for heart burn (Hiatal Hernia found). 50,000U cap of D2 for Vit D deficiency. Tried multiple anxiety medications to no prevail. Nov 2014: MEB started. No overall diagnosis. MEB package states "Inappropriate Tachycardia/ Melloadrenal Hyperfunction/ Idiopathic Blindness" as diagnosis' found within Dec 2013-Nov 2014. All listed as Chronic conditions.
Age: 21.0
Sex: M
Vaccine: ANTH
Symptoms: Dyspepsia, Dyspnoea, Fatigue, Headache, Hiatus hernia
Clinical narrative: Aug 2013: Experienced Complete Blindness w/ Exertion. Chest pain/Tachycardia/Dyspnea/High Blood Pressure/Headaches/Extreme heart Burn/Difficulty concentrating/focusing. March 2014: Symptoms worsened to include extreme fatigue, dyspnea progressed to having to rest after minor exertion. IBS potentiality. Vit D deficiency. Found melloadrenal hyperfunction. MIBG scan shows holding of adrenaline in kidneys. Anxiety. Put on Metoprolol 100mg for Heart Rate/BP. Zantac and Prilosec for heart burn (Hiatal Hernia found). 50,000U cap of D2 for Vit D deficiency. Tried multiple anxiety medications to no prevail. Nov 2014: MEB started. No overall diagnosis. MEB package states "Inappropriate Tachycardia/ Melloadrenal Hyperfunction/ Idiopathic Blindness" as diagnosis' found within Dec 2013-Nov 2014. All listed as Chronic conditions.
Age: 21.0
Sex: M
Vaccine: ANTH
Symptoms: Hypertension, Irritable bowel syndrome, Scan adrenal gland abnormal, Tachycardia, Vitamin D deficiency
Clinical narrative: Aug 2013: Experienced Complete Blindness w/ Exertion. Chest pain/Tachycardia/Dyspnea/High Blood Pressure/Headaches/Extreme heart Burn/Difficulty concentrating/focusing. March 2014: Symptoms worsened to include extreme fatigue, dyspnea progressed to having to rest after minor exertion. IBS potentiality. Vit D deficiency. Found melloadrenal hyperfunction. MIBG scan shows holding of adrenaline in kidneys. Anxiety. Put on Metoprolol 100mg for Heart Rate/BP. Zantac and Prilosec for heart burn (Hiatal Hernia found). 50,000U cap of D2 for Vit D deficiency. Tried multiple anxiety medications to no prevail. Nov 2014: MEB started. No overall diagnosis. MEB package states "Inappropriate Tachycardia/ Melloadrenal Hyperfunction/ Idiopathic Blindness" as diagnosis' found within Dec 2013-Nov 2014. All listed as Chronic conditions.
Age: 13.0
Sex: F
Vaccine: MMR, TDAP
Symptoms: Abnormal loss of weight, Antiacetylcholine receptor antibody, Asthenia, Blood thyroid stimulating hormone, Borrelia test
Clinical narrative: Abnormal weight loss, generalized weakness, trouble walking, fatigue, insomnia, failure to thrive (child), dizziness, chronic pain, depression. TREATMENTS medications: SNRI, scopolamine, promethazine, melatonin, Feeding tube placed. REFERRALS Occupational Therapy, Neurology, Pain Medicine, Dietician, Behavioral Medicine.
Age: 13.0
Sex: F
Vaccine: MMR, TDAP
Symptoms: Cytomegalovirus test, Depression, Dizziness, Epstein-Barr virus test, Failure to thrive
Clinical narrative: Abnormal weight loss, generalized weakness, trouble walking, fatigue, insomnia, failure to thrive (child), dizziness, chronic pain, depression. TREATMENTS medications: SNRI, scopolamine, promethazine, melatonin, Feeding tube placed. REFERRALS Occupational Therapy, Neurology, Pain Medicine, Dietician, Behavioral Medicine.
Age: 13.0
Sex: F
Vaccine: MMR, TDAP
Symptoms: Fatigue, Full blood count, Gait disturbance, Gastrointestinal tube insertion, Insomnia
Clinical narrative: Abnormal weight loss, generalized weakness, trouble walking, fatigue, insomnia, failure to thrive (child), dizziness, chronic pain, depression. TREATMENTS medications: SNRI, scopolamine, promethazine, melatonin, Feeding tube placed. REFERRALS Occupational Therapy, Neurology, Pain Medicine, Dietician, Behavioral Medicine.
Age: 13.0
Sex: F
Vaccine: MMR, TDAP
Symptoms: Metabolic function test, Mononucleosis heterophile test, Nuclear magnetic resonance imaging brain, Pain
Clinical narrative: Abnormal weight loss, generalized weakness, trouble walking, fatigue, insomnia, failure to thrive (child), dizziness, chronic pain, depression. TREATMENTS medications: SNRI, scopolamine, promethazine, melatonin, Feeding tube placed. REFERRALS Occupational Therapy, Neurology, Pain Medicine, Dietician, Behavioral Medicine.
Age: 83.0
Sex: M
Vaccine: FLU4, PNC13
Symptoms: Inflammation, Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: MILD SWELLING, ERYTHEMA, AND PRURITUS LOCALIZED TO THE AFFECTED ARM IN THE VICINITY OF INJECTION SITE (LEFT DELTOID). PATIENT STATES NO PAIN AND NO OBVIOUS SIGNS OF INFECTION (STREAKING, ETC). PATIENT DESCRIBED THE INFLAMMATION AS GETTING A BIT BETTER EACH DAY, BUT NO MEDICATION TAKEN. I RECOMMENDED LORATADINE OR FEXOFENADINE AND TOPICAL HYDROCORTISONE AS NEEDED AND TO CONTACT PHYSICIAN WITH ANY QUESTION, CONCERNS, OR IF CONDITION WORSENED OR NEW PAIN OR REDNESS DEVELOPED.
Age: 10.0
Sex: M
Vaccine: FLUN4
Symptoms: Abdominal pain, Dyspnoea, Oropharyngeal pain, Pyrexia
Clinical narrative: High fever, abdominal pain, sore throat, difficulty breathing.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Balance disorder, Blood test normal, Computerised tomogram, Dizziness, Hyperhidrosis
Clinical narrative: Vision impairment; nausea; sweating; dizziness; equilibrium impaired.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea, Neurological examination normal, Visual impairment
Clinical narrative: Vision impairment; nausea; sweating; dizziness; equilibrium impaired.
Age: 87.0
Sex: F
Vaccine: FLUX
Symptoms: Antineutrophil cytoplasmic antibody negative, Antinuclear antibody negative, C-reactive protein normal, Dermatitis, Differential white blood cell count
Clinical narrative: Acute onset of pruritis dermatitis symptoms with onset within 24 hours of vaccination; I evaluated the patient approximately 6 weeks following vaccination and diagnosed her with presumed vasculitic urticaria.  She responded to treatment with a prednisone burst and taper.  Lab testing was negative for the autoimmune markers of vasculitis including ANCA. The patient was asymptomatic at follow up (12/30/2014).  The timing suggests an adverse reaction to the influenza vaccine. Details of the vaccination (lot, manufacture...) are not available.
Age: 87.0
Sex: F
Vaccine: FLUX
Symptoms: Full blood count normal, Glucose urine present, Hypersensitivity vasculitis, Metabolic function test, Pruritus
Clinical narrative: Acute onset of pruritis dermatitis symptoms with onset within 24 hours of vaccination; I evaluated the patient approximately 6 weeks following vaccination and diagnosed her with presumed vasculitic urticaria.  She responded to treatment with a prednisone burst and taper.  Lab testing was negative for the autoimmune markers of vasculitis including ANCA. The patient was asymptomatic at follow up (12/30/2014).  The timing suggests an adverse reaction to the influenza vaccine. Details of the vaccination (lot, manufacture...) are not available.
Age: 87.0
Sex: F
Vaccine: FLUX
Symptoms: Red blood cell sedimentation rate normal, Vaccination complication
Clinical narrative: Acute onset of pruritis dermatitis symptoms with onset within 24 hours of vaccination; I evaluated the patient approximately 6 weeks following vaccination and diagnosed her with presumed vasculitic urticaria.  She responded to treatment with a prednisone burst and taper.  Lab testing was negative for the autoimmune markers of vasculitis including ANCA. The patient was asymptomatic at follow up (12/30/2014).  The timing suggests an adverse reaction to the influenza vaccine. Details of the vaccination (lot, manufacture...) are not available.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Discomfort, Injection site erythema, Injection site mass, Injection site pruritus, Injection site swelling
Clinical narrative: Red, swollen, itchy, lump about size of half dollar at injection site. 4 days later began with itchy rash. It continued to spread for the next 3 days all over my body! Taking 50mg of Benadryl every 6 hours. Very uncomfortable!!!
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash generalised, Rash pruritic
Clinical narrative: Red, swollen, itchy, lump about size of half dollar at injection site. 4 days later began with itchy rash. It continued to spread for the next 3 days all over my body! Taking 50mg of Benadryl every 6 hours. Very uncomfortable!!!
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Areflexia, Electromyogram abnormal, Hypoaesthesia, Lumbar puncture, Nuclear magnetic resonance imaging
Clinical narrative: Numbness/Tingling of bilateral extremities starting at feet ascending to waist.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Paraesthesia
Clinical narrative: Numbness/Tingling of bilateral extremities starting at feet ascending to waist.
Age: 85.0
Sex: M
Vaccine: FLU3
Symptoms: Haemorrhage, Pain, Swelling, Tenderness
Clinical narrative: Pt. revealed pooling of blood inner bicep, soreness on deltoid, swollen area on deltoid, tender, called MD, MD asked pt. to call back if progresses, Rph recommended cold compress.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash
Clinical narrative: Patient came into pharmacy and had rash on injection site area. She said it was slightly itchy and is red. She went to emergency room was told it was fine. A reaction to injection. No medications/treatment was given. Not shingles.
Age: 0.57
Sex: M
Vaccine: DTAPHEPBIP, FLU3, PNC13
Symptoms: Blister, Erythema, Pyrexia
Clinical narrative: Fever 103.9 the morning after vaccines given with superficial localized erythema matching bandaid location w/2 to 3mm vesicles at corner of bandaid. No significant induration.
Age: 10.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: 1 cm circle of redness around injection site of right deltoid. Redness 15 1/2 inch away from injection site and is 4x5 - 4.25 inches wide, wrapping around bicep and 4 inches vertically. Warm to touch. Noticed this morning when child woke up, but was a little swollen around injection site last night.
Age: 45.0
Sex: M
Vaccine: MMR
Symptoms: Peripheral swelling, Rash, Urticaria
Clinical narrative: Swelling of (L) hand, urticaria and faint rash on (L) hand approximately 2 hr post vaccination. Urticaria and rash resolved with po BENADRYL-2 doses. Swelling initially improved but has returned.
Age: 1.34
Sex: F
Vaccine: HEP, HIBV, MMR, VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Pt has chickenpox after vaccination.
Age: 0.17
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Haematochezia, Mucous stools, Occult blood positive
Clinical narrative: Spots of blood and mucous in stool, since 12-27-14. Stool test positive for fecal occult blood (Hemoccult) in physician's office.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Pruritus generalised
Clinical narrative: Appt at 11AM today HPV #3 given Mom called at 1:30 to report child c/o itchy on chin, neck, chest, armpit and stomach. Denied any difficulty breathing or swallowing or dizziness.
Age: 22.0
Sex: M
Vaccine: ANTH, HEPAB, SMALL, TYP, YF
Symptoms: Activities of daily living impaired, Rash generalised
Clinical narrative: This case was received on 03 September 2013 via a third party query tool search on the VAERS database, under reference number 490946. A 22 year-old male patient had received on 18 April 2012 a left arm injection of ACAM2000 (lot number VV04003A), an intramuscular right arm injection of TYPHIM VI (lot number G1124), an intramuscular right arm injection of YF-VAX (lot number UH278AA), an intramuscular right arm injection of Anthrax vaccine (other manufacturer, lot number FAV307), and an intramuscular left arm injection of TWINRIX (other manufacturer, lot number AHABB223CA). Eleven days later on 29 April 2012, the subject experienced a generalized rash and activities of daily living were impaired. The patient went to the emergency room on 29 April 2012 for the rash which was all over his body and was treated with BENADRYL and steroid. The patient stated he did not take the steroid medications. Follow-up with the PCM occurred on 30 April 2012. The patient returned to duty but was restricted from some duties. He had active orders for ZANTAC and prednisone. The patient had no current illnesses and no medical history. No further information was available at the time of the report. The patient's outcome was reported as recovered. Documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Back pain, Chest discomfort, Chest pain, Feeling abnormal, Muscle tightness
Clinical narrative: This case was received on 03 September 2013 via a third party query tool search on the VAERS database, under reference number 490958. A 22 year-old male patient had received on 17 April 2013 a left arm injection of ACAM2000 (lot number VV04003A), an intramuscular right arm injection of TYPHIM VI (lot number H14821), and an intramuscular right arm injection of Anthrax vaccine (other manufacturer, lot number FAV317A). Sixteen days later on 03 May 2013, the subject experienced back pain, chest discomfort, chest pain, feeling abnormal, muscle tightness, and swelling. The swelling (right jaw) lasted 3 days and the chest/back pain/tightness lasted 2 days. The patient also reported feeling as if a "rope was tied around him". The patient's medical history was not reported. No further information was available at the time of the report. The patient's outcome was not reported. Documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Swelling
Clinical narrative: This case was received on 03 September 2013 via a third party query tool search on the VAERS database, under reference number 490958. A 22 year-old male patient had received on 17 April 2013 a left arm injection of ACAM2000 (lot number VV04003A), an intramuscular right arm injection of TYPHIM VI (lot number H14821), and an intramuscular right arm injection of Anthrax vaccine (other manufacturer, lot number FAV317A). Sixteen days later on 03 May 2013, the subject experienced back pain, chest discomfort, chest pain, feeling abnormal, muscle tightness, and swelling. The swelling (right jaw) lasted 3 days and the chest/back pain/tightness lasted 2 days. The patient also reported feeling as if a "rope was tied around him". The patient's medical history was not reported. No further information was available at the time of the report. The patient's outcome was not reported. Documents held by sender: none.
Age: 23.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Influenza like illness, Injection site erythema, Injection site pain, Injection site swelling, Lymphadenopathy
Clinical narrative: This case was received on 03 September 2013 via a third party query tool search on the VAERS database, under reference number 491055. A 23-year-old male patient had received on 26 April 2013 a dose of ACAM2000 (lot number VV04003A), an intramuscular (also reported as TYPHIMVI (lot number H14811) and an intramuscular injection of EMERGENT (lot number FAV317A) and on 05 May 2013, experienced pain 5/10 at site and enlarged, tender axillary nodes accompanied by mild swelling and erythema of the in site and flu-like symptoms. The patient had an emergency visit. Other medications included multivitamins. Lab data, history and current illnesses were reported as none. Prior vaccinations were not reported. No further information was available at the time of the report. The patient's outcome was unknown. Documents held by sender: none.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: This case was received on 03 September 2013 via a third party query tool search on the VAERS database, under reference number 492740. A 21 year-old male patient had received on 07 May 2013 dose 0, left arm injection of ACAM2000 (lot number VV04003A), a dose 0 intramuscular (also reported as Typhoid live oral) right arm injection of TYPHIM VI (lot number H1482) and a dose 0 intramuscular right arm injection of Anthrax (Emergent, lot number FAV317A) and 16 days later on 23 May 2013, experienced pruritus and thought it was bug bites. On 25 May 2013, the patient noticed hives/rashes on legs and arms. History was none/NKA-NKDA (no known allergies and no known drug allergies). Current illnesses was reported as none. Prior vaccinations, Other medications and Lab data were not reported. No further information was available at the time of the report. The patient's outcome was not recovered. Documents held by sender: none.
Age: 23.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Post vaccination autoinoculation, Skin lesion
Clinical narrative: This case was received on 17 September 2013 via a third party query tool search on the VAERS database, under reference number 493499. A 23 year-old male patient with no past medical history had received the following vaccinations on 29 May 2013: a dose of ACAM2000 (lot number, route and site of administration not reported), an intramuscular injection (also reported as typhoid live oral) of TYPHIM VI (lot number H1481) (site of administration not reported) and an intramuscular injection of anthrax (Emergent, lot number FAV322A) (site of administration not reported) and seven days later on 05 June 2013, was found to have diffuse lesions to anterior aspect of trunk. "Appear to be self inoculation sites of smallpox". Treatments were not reported. No further information was available at the time of the report. The patient's outcome was not reported. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Age: 24.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Rash generalised
Clinical narrative: This case was received on 17 September 2013 via a third party query tool search on the VAERS database, under reference number 493665. A 24-year-old male patient had received the following vaccinations on 30 May 2013: an injection of ACAM2000 (lot number VV04003A) in the arm, TYPHIM VI (Sanofi Pasteur SA, lot number H1482) in the arm, and BIOTHRAX (Emergent, lot number FAV003A) in the arm. On 07 June 2013, 8 days later, the patient had a questionable robust take. Vital signs were: pulse 92, respiratory 20, blood pressure 160/72, temperature 97.4 and PSO2 96%. The patient had a rash anterior and posterior from head to toe. He was alert and oriented and transported to the emergency room. The patient had no other medications, a current illness of rash, elevated pulse and blood pressure and anxiety as well as a history of allergies to all ceclor, sulfa and blueberry. Outcome was unknown. Documents held by sender: none.
Age: 22.0
Sex: U
Vaccine: SMALL, TYP
Symptoms: Musculoskeletal discomfort, Rash, Skin lesion
Clinical narrative: This case was received on 25 November 2013 via a third party query tool search on the VAERS database, under reference number 498211. A 22 year-old patient (gender not reported) with a history of chicken pox as a child had received the following vaccinations on 15 July 2013: an injection of smallpox (vaccinia) vaccine, ACAM2000, lot number VV04003A and an intramuscular injection of TYPHIM VI (lot number G1542) and on 30 July 2013, had an onset of discomfort in mid back right side. The next day noted lesions on back that were still achy. Symptoms rash other nonspecific skin eruption disturbance of skin sensation. Treatments were not reported. Other medications and current illnesses were reported as none. Lab data and prior vaccinations were not reported. No further information was available at the time of the report. The patient's outcome was unknown. Documents held by sender: none.
Age: 27.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Injection site erythema, Injection site inflammation, Injection site swelling
Clinical narrative: Initial information was received on 25 November 2013 via a third party query tool search on the VAERS database, under reference number 499299. A 27 year old male patient received the following vaccinations on 01 August 2013 ACAM200 (lot number CC04003A) in the left arm, TYPHIM (Sanofi Pasteur SA, lot number H1482) intramuscularly in the right arm, and BIOTHRAX (lot number FAV322A) intramuscularly in the right arm. On 12 August 2013, the patient presented with a large amount of redness and swelling around the smallpox site. The inflammation and redness covered most of the deltoid with a few spots on the inside of the arm. The patient had no other issues at the time and was instructed to keep the site covered with a different bandage and monitor the site for increased size or any changes in medical condition. The patient's concomitant medications and medical history were not reported. The patient had no current illnesses. The outcome was reported as unknown. Documents held by sender: None.
Age: 27.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Headache, Pyrexia, Rash
Clinical narrative: This case was received on 25 November 2013 via a third party query tool search on the VAERS database, under reference number 499711. A 27-year-old male patient had received the following vaccinations on 08 August 2013: ACAM2000 (lot number VV04003A) in the arm, TYPHIM VI (Sanofi Pasteur, lot number H1482) in the right arm, and BIOTHRAX (lot number FAV328A) in the right arm. Ten days later, on 18 August 2013 (also reported as two weeks later) the patient experienced headaches, slight fever and rash. The rash was localized to the ankles, waist, forearms, chest and face. Lab data and other medications were not reported. Current illnesses and history were reported as none. Outcome was unknown. Documents held by sender: none.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Axillary pain, Injection site reaction, Scab, Spinal pain
Clinical narrative: This case was received on 04 December 2013 via a third party query tool search on the VAERS database, under reference number 502067. A 19-year-old male patient had received the following vaccinations on 16 August 2013: ACAM2000 (lot number VV04003A), TYPHIM VI (lot number H1482), and BIOTHRAX (lot number FAV322A). On 23 August 2013, also reported as 25 August 2013 when he was two weeks post smallpox immunization, there was concern regarding the (expected) black crusting at the site. he had significant pain 6/10 in left axilla and spine. The patient had no headache, fever, chest pain and shortness of breath (SOB). On 30 August 2013, the patient was much better with only axillary pain of 2/10. lab data, other medication, current illness and history were not reported. Outcome was unknown. Documents held by sender: none
Age: 29.0
Sex: F
Vaccine: ANTH, FLUN4, SMALL, TYP
Symptoms: Chills, Headache, Lymphadenopathy, Malaise, Pain
Clinical narrative: This case was received on 04 December 2013 via a third party tool search on the VAERS database, under reference number: 503101. A 29 year-old female patient had received the following vaccinations on 04 September 2013: a right arm injection of ACAM2000 (lot number VV04003A), an intramuscular left arm injection of TYPHIM VI (lot number H14821), an intranasal FLUMIST (MedImmune lot number BH2026) and an intramuscular left arm injection of BIOTHRAX (Emergent, lot number FAV310) and on 14 September 2013, experienced chills, headache, malaise, body aches, rash and right axillary lymphadenopathy that lasted for four days. Developed a papular rash on trunk on 18 September 2012 and went to ER. Treatments were not reported. Other medications were reported as norethindroneacetate and ethyl estradiol. Lab data was none. History and current illnesses were no. Prior vaccinations were not reported. No further information was available at the time of the report. The patient's outcome was unknown. Documents held by sender: none.
Age: 29.0
Sex: F
Vaccine: ANTH, FLUN4, SMALL, TYP
Symptoms: Rash, Rash papular
Clinical narrative: This case was received on 04 December 2013 via a third party tool search on the VAERS database, under reference number: 503101. A 29 year-old female patient had received the following vaccinations on 04 September 2013: a right arm injection of ACAM2000 (lot number VV04003A), an intramuscular left arm injection of TYPHIM VI (lot number H14821), an intranasal FLUMIST (MedImmune lot number BH2026) and an intramuscular left arm injection of BIOTHRAX (Emergent, lot number FAV310) and on 14 September 2013, experienced chills, headache, malaise, body aches, rash and right axillary lymphadenopathy that lasted for four days. Developed a papular rash on trunk on 18 September 2012 and went to ER. Treatments were not reported. Other medications were reported as norethindroneacetate and ethyl estradiol. Lab data was none. History and current illnesses were no. Prior vaccinations were not reported. No further information was available at the time of the report. The patient's outcome was unknown. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: ANTH, FLUN4, SMALL, TYP
Symptoms: Rash erythematous, Rash generalised, Rash pruritic
Clinical narrative: This case was received on 07 January 2014 via a third party query tool search on the VAERS database, under reference number 510446. A 26-year-old patient had received the following vaccinations on 02 October 2013: ACAM2000 (SP Biologics Co. lot number VV04003A) in the left arm, dose 4 FLUMIST QUADRIVALENT (MedImmune, lot number BH2026) via the intranasal route, VIVOTIF (Berna, lot number 3000427 by mouth, and BIOTHRAX (Emergent, lot number FAV328A) via the intramuscular route in the right arm. On 25 October 2013 at 0600, the patient experienced a rash all over the body with small red bumps that itched and were annoying. The patient saw a physician on 30 October 2013 who placed him on 48 hours quarters, treated with medication and permanently exempted him from the smallpox vaccine. The patient required an emergency visit. Lab data, other medication, current illnesses and history were reported as none. Outcome was recovered. Documents held by sender: none.
Age: 39.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Abdominal pain, Influenza like illness, Nausea, Urticaria
Clinical narrative: This case was received on 15 April 2014 via a third party query tool search on the VAERS database, under reference number 519097. A 39 year old male patient, with no reported medical history, received the following vaccines on 8 January 2014: a left arm injection of ACAM2000, (lot number not reported); an intramuscular right arm injection of TYPHIM VI (lot number J12011); and a right arm intramuscular injection of BIOTHRAX (lot number FAV323A). The patient was taking NEXIUM and ZYRTEC concomitantly, and was not ill at the time of vaccination. On 10 January 2014, i.e. 2 days post vaccination, he complained of abdominal pain, nausea, and "felt like he had the flu". Four days post-vaccination, on 12 January 2014, he developed hives on his forehead and then all over his body. He was referred to a physician, who prescribed antibiotics, TORADOL, "adderax", naproxen and magic mouth wash. The patient had not yet recovered at the time of the report. Documents help by sender: None
Age: 23.0
Sex: M
Vaccine: ANTH, MMR, SMALL, TYP, ANTH, MMR, SMALL, TYP
Symptoms: Chest discomfort, Computerised tomogram, Dyspnoea, Electrocardiogram, Laboratory test
Clinical narrative: This case was received on 15 April 2014 via a third party query tool search on the VAERS database, under reference number 520255. A 23 year-old male patient had received the following vaccinations on 11 January 2014: a dose 1 left arm injection of ACAM2000 (lot number VV04003A), a dose 1 intramuscular right arm injection of TYPHIM VI (lot number K1183) and a dose 1 intramuscular right arm injection of BIOTHRAX (Emergent, lot number FAV394A) and a dose 2 subcutaneous right arm injection of MMR (Merck lot number J006995) and eight days later on 19 January 2014, experienced midsternal chest pressure and difficulty breathing. He was evaluated in the emergency room where he had lab work, EKG and CT scan (results were not reported). Treatments were not reported. Current illnesses, history and other medications were reported as none. Prior vaccinations were not reported. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
Age: 23.0
Sex: M
Vaccine: ANTH, MMR, SMALL, TYP, ANTH, MMR, SMALL, TYP
Symptoms: Blood test, Chest discomfort, Computerised tomogram, Dyspnoea, Electrocardiogram
Clinical narrative: This case was received on 15 April 2014 via a third party query tool search on the VAERS database, under reference number 520255. A 23 year-old male patient had received the following vaccinations on 11 January 2014: a dose 1 left arm injection of ACAM2000 (lot number VV04003A), a dose 1 intramuscular right arm injection of TYPHIM VI (lot number K1183) and a dose 1 intramuscular right arm injection of BIOTHRAX (Emergent, lot number FAV394A) and a dose 2 subcutaneous right arm injection of MMR (Merck lot number J006995) and eight days later on 19 January 2014, experienced midsternal chest pressure and difficulty breathing. He was evaluated in the emergency room where he had lab work, EKG and CT scan (results were not reported). Treatments were not reported. Current illnesses, history and other medications were reported as none. Prior vaccinations were not reported. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
Age: 28.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Rash papular, Rash pruritic
Clinical narrative: This case was received on 15 April 2014 via a third party query tool search on the VAERS database, under reference number 520705. A 28-year-old male patient, with no reported medical history and no illness at the time of vaccination, received the following vaccinations on 10 January 2014: ACAM2000, (lot number VV04003A); TYPHIM VI (lot number J16311); and BIOTHRAX (lot number PAV341A). On 22 January 2014, i.e. 12 days post-vaccination, the patient developed a nonspecific pruritic popular rash on bilateral shoulders, upper chest, upper back, and neck. No laboratory testing was performed. At the time of the report, symptoms were ongoing, and recovery was reported as unknown. Documents held by sender: None
Age: 22.0
Sex: M
Vaccine: ANTH, FLU3, SMALL, TYP, ANTH, FLU3, SMALL, TYP
Symptoms: Dysphagia, Dyspnoea, Headache, Injection site erythema, Injection site swelling
Clinical narrative: This case was received on 14 April 2014 via a third party query tool search on the VAERS database, under reference number 520706. A 22 year-old male patient had received the following vaccines on 11 January 2014: a left arm injection of ACAM2000 (lot number VV04003A), a right arm intramuscular injection of Typhoid VI polysaccharide vaccine, lot number K1183, a right arm intramuscular injection of AFLURIA (CSL Limited, lot number 08849221A) and a right arm intramuscular injection of Anthrax vaccine (Emergent, lot number FAV349A). On 20 January 2014, 9 days following vaccination the patient experienced dysphagia, dyspnea, headache, injection site erythema, injection site swelling and oropharyngeal pain. The patient had feelings that he can't catch his breath and his smallpox site was very red and raised. He was treated with Azithromycin for systemic symptoms. The patient's medical history, current illnesses and concomitant medications were reported as none. Laboratory data "will follow up with primary physician on 27 January". The patient outcome is unknown. Documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: ANTH, FLU3, SMALL, TYP, ANTH, FLU3, SMALL, TYP
Symptoms: Oropharyngeal pain
Clinical narrative: This case was received on 14 April 2014 via a third party query tool search on the VAERS database, under reference number 520706. A 22 year-old male patient had received the following vaccines on 11 January 2014: a left arm injection of ACAM2000 (lot number VV04003A), a right arm intramuscular injection of Typhoid VI polysaccharide vaccine, lot number K1183, a right arm intramuscular injection of AFLURIA (CSL Limited, lot number 08849221A) and a right arm intramuscular injection of Anthrax vaccine (Emergent, lot number FAV349A). On 20 January 2014, 9 days following vaccination the patient experienced dysphagia, dyspnea, headache, injection site erythema, injection site swelling and oropharyngeal pain. The patient had feelings that he can't catch his breath and his smallpox site was very red and raised. He was treated with Azithromycin for systemic symptoms. The patient's medical history, current illnesses and concomitant medications were reported as none. Laboratory data "will follow up with primary physician on 27 January". The patient outcome is unknown. Documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Rash generalised
Clinical narrative: This case was received on 12 May 2014 via a third party query tool search on the VAERS database, under reference number 521760. A 22 year old male patient received the following vaccinations on 15 January 2014: ACAM2000 (lot number VV04003A into the left arm), TYPHIM VI intramuscularly (lot number J1629 site not reported) and BIOTHRAX intramuscularly (lot number FAV349A, site not reported). On 29 January 2014, the patient experienced a rash through his body (wrists, stomach, waistline, face and legs). The rash developed 15 days after the vaccination. The patient's medical history and concomitant medications were not reported. Laboratory data was not reported. The patient outcome is recovered. Documents held by sender: None. There may be a discrepancy between the event date field and the onset date information in the free text narrative in the data reported. Latency has been calculated using the event date field.
Age: 19.0
Sex: F
Vaccine: ANTH, FLUC3, SMALL, TYP, ANTH, FLU3, SMALL, TYP
Symptoms: Exposure during pregnancy, Pregnancy test negative
Clinical narrative: This case was received on 12 May 2014 via a third party query tool search on the VAERS database, under the reference number 521812, and is a case of vaccine exposure during pregnancy. A 19-year-old female patient received the following vaccinations on 08 January 2014: ACAM2000 (lot number VV04003A), TYPHIM Vi (lot number H14821); anthrax (Emergent, lot number FAV324A); and FLU3 (Novartis, lot number 005011A). The patient had no medical history or illness at time of vaccination. Prior to vaccination, the patient underwent a pregnancy test which was negative. On 03 February 2014, a subsequent pregnancy test was positive; this was later confirmed. The patient had no reported adverse events. Outcome was unknown. Documents held by sender: None.
Age: 19.0
Sex: F
Vaccine: ANTH, FLUC3, SMALL, TYP, ANTH, FLU3, SMALL, TYP
Symptoms: Exposure during pregnancy, No adverse event, Pregnancy test positive
Clinical narrative: This case was received on 12 May 2014 via a third party query tool search on the VAERS database, under the reference number 521812, and is a case of vaccine exposure during pregnancy. A 19-year-old female patient received the following vaccinations on 08 January 2014: ACAM2000 (lot number VV04003A), TYPHIM Vi (lot number H14821); anthrax (Emergent, lot number FAV324A); and FLU3 (Novartis, lot number 005011A). The patient had no medical history or illness at time of vaccination. Prior to vaccination, the patient underwent a pregnancy test which was negative. On 03 February 2014, a subsequent pregnancy test was positive; this was later confirmed. The patient had no reported adverse events. Outcome was unknown. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Erythema, Skin lesion
Clinical narrative: This case was received on 12 May 2014 via a third party query tool search on the VAERS database, under reference number 522441. A 22 year-old male patient with no known drug allergies and no chronic medical conditions had received the following vaccines on 31 January 2014: a dose 1 left arm injection of ACAM2000, (lot number VV04003A), a dose 1 intramuscular right arm injection of Typhoid VI polysaccharide vaccine, lot number J1629 and a dose 1 intramuscular right arm injection of BIOTHRAX, (lot number FAV349A) and six days later on 06 February 2014, patient developed round, red lesions on trunk, left and right arm of body. Lab data and prior vaccinations were not reported. No further information was available at the time of the report. Outcome was not reported. Documents held by sender: none.
Age: 25.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Blister, Rash pustular
Clinical narrative: Initial case received on 16 June 2014 via a third party query tool search on the VAERS database, under reference number 524439. A 25-year-old female patient, with no medical history and no current illness, had received a percutaneous injection of ACAM2000 (lot number VV04003A) in the right arm, concomitantly with an intramuscular injection of TYPHIM VI vaccine (lot number J1631) in the left arm and an intramuscular dose of BIOTHRAX vaccine (other manufacturer, lot number FAV349A) in the left arm on 21 February 2014. The patient did not receive any other medication. It was not reported whether the patient had received prior vaccination. On 02 March 2014, approximately 9 days post vaccination; she developed erythematous pustules and vesicles down the right arm. Blister and rash pustular were also reported. It was not reported whether the patient had received corrective treatment. Lab data were reported as none. Outcome was reported as recovery unknown. Note: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of patient's vaccination. Documents held by sender: none.
Age: 25.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Blister, Erythema, Rash pustular
Clinical narrative: Initial case received on 16 June 2014 via a third party query tool search on the VAERS database, under reference number 524439. A 25-year-old female patient, with no medical history and no current illness, had received a percutaneous injection of ACAM2000 (lot number VV04003A) in the right arm, concomitantly with an intramuscular injection of TYPHIM VI vaccine (lot number J1631) in the left arm and an intramuscular dose of BIOTHRAX vaccine (other manufacturer, lot number FAV349A) in the left arm on 21 February 2014. The patient did not receive any other medication. It was not reported whether the patient had received prior vaccination. On 02 March 2014, approximately 9 days post vaccination; she developed erythematous pustules and vesicles down the right arm. Blister and rash pustular were also reported. It was not reported whether the patient had received corrective treatment. Lab data were reported as none. Outcome was reported as recovery unknown. Note: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of patient's vaccination. Documents held by sender: none.
Age: 26.0
Sex: F
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Initial case received on 16 June 2014 via a third party query tool search on the VAERS database, under reference number 525284. A 26-year-old female patient, with no reported medical history and no current illness, had received a percutaneous injection of ACAM2000 (lot number unknown) in the left arm and also received a dose 2 of Anthrax vaccine (Emergent lot number FAV349A intramuscularly into the left arm on 01 March 2014. The patient was previously seen on 25 February 2014 and received Typhoid Vaccine, batch, route, site and manufacturer not reported, TWINRIX vaccine (batch, route, site and manufacturer not reported and Anthrax first dose, Emergent, batch, route, site and manufacturer not reported. The patient also developed erythematous pustules and vesicles down arm (inoculated arm), date not reported. Lab data were reported as none. Outcome was reported as recovery unknown. The event of inappropriate schedule of drug administration was the only coding included from the VAERS database; however the events of erythematous pustules and vesicles down inoculated arm were mentioned in the narrative and therefore were also coded. The reported drugs of Smallpox and Anthrax were included in the coding from the VAERS database, but Typhoid, TWINRIX and Anthrax were given previously on 25 February 2014 and were also coded as suspect vaccines. Documents held by sender: None.
Age: 26.0
Sex: F
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Blister, Erythema, Inappropriate schedule of drug administration, Rash pustular
Clinical narrative: Initial case received on 16 June 2014 via a third party query tool search on the VAERS database, under reference number 525284. A 26-year-old female patient, with no reported medical history and no current illness, had received a percutaneous injection of ACAM2000 (lot number unknown) in the left arm and also received a dose 2 of Anthrax vaccine (Emergent lot number FAV349A intramuscularly into the left arm on 01 March 2014. The patient was previously seen on 25 February 2014 and received Typhoid Vaccine, batch, route, site and manufacturer not reported, TWINRIX vaccine (batch, route, site and manufacturer not reported and Anthrax first dose, Emergent, batch, route, site and manufacturer not reported. The patient also developed erythematous pustules and vesicles down arm (inoculated arm), date not reported. Lab data were reported as none. Outcome was reported as recovery unknown. The event of inappropriate schedule of drug administration was the only coding included from the VAERS database; however the events of erythematous pustules and vesicles down inoculated arm were mentioned in the narrative and therefore were also coded. The reported drugs of Smallpox and Anthrax were included in the coding from the VAERS database, but Typhoid, TWINRIX and Anthrax were given previously on 25 February 2014 and were also coded as suspect vaccines. Documents held by sender: None.